Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 351.80
+10.90 (3.20%)
Aug 14, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 796.03 million as of August 14, 2025. Its market cap has increased by 11.11% in one year.
Market Cap
796.03M
Enterprise Value
655.90M
Revenue
36.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
351.80
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 796.03M, an increase of 1,509.79%. That is a compound annual growth rate of 8.70%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 64.35B |
| Danel (Adir Yeoshua) | 2.50B |
| Kamada | 1.44B |
| Bait Bakfar | 1.05B |
| SofWave Medical | 977.04M |
| BrainsWay | 772.64M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 675.99M |